Skip to content

Educational Pharmaceutical Care program for Newly Diagnosed Diabetes Mellitus Patients.

Integrated Pharmaceutical Care Programme in Patients with Diabetes Mellitus An Interventional Cross Sectional Prospective Study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067435
Enrollment
282
Registered
2024-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Give Education and councelling: formulation and intervention of working model of Diabetes mellitus educational pharmaceutical care for 4 times during 16 month time period. every 4 month

Sponsors

Rishita Patel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Type-II diabetes mellitus. Patients with HbA1c more than 7%. Patients who receiving oral hypoglycemic and/or insulin therapy. Patients who provide written informed consent. Patients who express willingness to participate in the study.

Exclusion criteria

Exclusion criteria: Patients who are younger than 18 years (They are legally regarded as dependents and consequently they cannot take decisions of their own). Pregnant Women. Patients who will not willing to give consent to participate.

Design outcomes

Primary

MeasureTime frame
Reduction in HbA1C levels in intervention groupTimepoint: Reduction in HbA1C levels exactly after 4 Times in each 4 month intervention during 16 month study period

Secondary

MeasureTime frame
enhancing patients quality of life in the form of reduction of symptoms improving self-management of disease & achieving goal of health promotion & prevention of progression of diabetes mellitusTimepoint: exactly 4 times( each 4 months) Intervention during 16 months study period

Countries

India

Contacts

Public ContactRishita Patel

INDUKAKA IPCOWALA COLLEGE OF PHARMACY

harshaben.patel@cvmu.edu.in8758149590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026